|1.||Smith, Richard J H: 11 articles (11/2014 - 09/2007)|
|2.||Zhang, Yuzhou: 7 articles (11/2014 - 11/2010)|
|3.||Sethi, Sanjeev: 7 articles (06/2014 - 09/2007)|
|4.||Padeletti, Luigi: 6 articles (06/2015 - 03/2004)|
|5.||Pickering, Matthew C: 6 articles (06/2014 - 09/2007)|
|6.||Chan, Danny: 5 articles (09/2015 - 12/2005)|
|7.||Cheung, Kenneth M C: 5 articles (09/2015 - 12/2005)|
|8.||Lelakowski, Jacek: 5 articles (01/2015 - 01/2005)|
|9.||Zipfel, Peter F: 5 articles (11/2014 - 09/2007)|
|10.||Cook, H Terence: 5 articles (01/2014 - 09/2007)|
|1.||Sick Sinus Syndrome
12/01/2002 - "Although atrial pacing is a more physiological mode of stimulation in sinus node dysfunction, the pacing modes most often are used DDD and VVI. The aim of our study was to demonstrate that AAI/AAIR pacing is effective and safe by analyzing the complications and mortality of this pacing mode in a long-term follow-up study. "
10/01/1988 - "Palpitation and general wellbeing were significantly improved during DDD pacing in the eight patients with sick sinus syndrome. "
01/01/2015 - "According to the current guidelines, atrioventricular (DDD) pacing is superior to atrial pacing (AAI) in the treatment of sick sinus syndrome (SSS). "
12/01/2003 - "Another trial the Pacemaker Selection in the Elderly (PASE) did suggest that for sinus node disease, DDD-R pacing may lead to an improvement in quality of life mainly early post implant. "
01/01/2015 - "The study enrolled 50 consecutive patients with prolonged PQ interval who were implanted with DDD pacemaker because of sinus node disease. "
10/01/1999 - "We have performed a prospective, randomized, multicentre study to evaluate the efficacy of DDDR and DDD pacing modes in preventing paroxysmal atrial fibrillation (PAF) episodes in patients with brady-tachy syndrome and CI. "
03/01/2005 - "Several prospective randomised clinical trials have reported that atrial-based "physiologic" AAI(R)- or DDD(R)-pacing is associated with a lower incidence of paroxysmal and permanent atrial fibrillation than single-chamber ventricular pacing in patients with a conventional pacemaker indication. "
10/01/2002 - "The aim of the study was 1) to evaluate the cumulative survival and the events capable of modifying it, 2) to evaluate the stability of sinus rhythm, and 3) to try to identify patients who are at a higher risk of developing permanent atrial fibrillation after DDD implantation. "
10/01/2000 - "Accordingly, the aim of the present study was to correlate electrophysiological data, in terms of atrial refractoriness, conduction parameters, and propensity to atrial fibrillation induction, and the likelihood of atrial fibrillation after DDD device implantation. "
07/01/2015 - "At 3 years of follow-up, the atrial fibrillation burden was not significantly reduced with SafeR versus DDD (median 0.00%, interquartile range [0.00% to 0.23%] versus median 0.01%, interquartile range [0.00% to 0.44%], respectively, P=0.178]), despite a persistent reduction in the median proportion of ventricular-paced beats (10% with DDD compared to 0% with SafeR). "
|3.||Hypertrophic Cardiomyopathy (Asymmetric Septal Hypertrophy)
06/01/2000 - "All patients with hypertrophic obstructive cardiomyopathy included in this multicenter study were either refractory or intolerant to drugs and typically had pressure gradients higher than 30 mm Hg. In 83 patients, mean age 53 (18 to 82) years who responded favorably to a temporary pacing test, a DDD pacemaker was implanted. "
06/15/2006 - "In conclusion, DDD pacing is effective in reducing the LVOT gradient and improving functional capacity in adult patients with hypertrophic cardiomyopathy. "
01/01/1996 - "DDD pacing has been advocated as an effective treatment for drug refractory obstructive hypertrophic cardiomyopathy. "
07/15/2011 - "A case of hypertrophic cardiomyopathy with mid-ventricular obstruction (MVO) -- dramatic long-term improvement with a DDD pacemaker as assessed by diastolic paradoxical jet flow velocity."
12/01/1994 - "We previously reported that 6 to 12 weeks of dual-chamber (DDD) pacing results in clinical and hemodynamic improvement in obstructive hypertrophic cardiomyopathy (HCM). "
06/01/2012 - "The aim of this study was to determine whether elderly patients who have implanted pacemakers for complete atrioventricular block gain significant benefits from dual-chamber (DDD) pacemakers compared with single chamber ventricular (VVIR) pacemakers. "
02/01/2001 - "The analyzed DDD/AMC mode-switch algorithm leads to a significant reduction of ventricular pacing in patients with spontaneous AV conduction or with only paroxysmal AV block. "
01/01/2014 - "The study population consisted of 40 patients with a DDD pacemaker implanted for third degree AV block and preserved LV systolic function (19 men; mean age 64.3 ± 10.9 years). "
07/01/2011 - "The aim of the present study was to assess the effect of different AVDs on LA and LAA functions in DDD pacemaker implanted patients with atrioventricular block. "
05/01/2010 - "The aim of the study was to determine whether elderly patients with implanted pacemaker for complete atrioventricular block gain significant benefit from dual-chamber (DDD) compared with single-chamber ventricular demand (VVIR). "
01/01/2013 - "Immediately after the device was upgraded to the DDD-biventricular pacemaker, the patient's heart failure symptoms and cardiac function dramatically improved, which suggests that AV dissociation has a much more negative impact on the cardiac function than AF in patients with CHF."
01/01/2015 - "Twelve CRT patients with non-ischemic heart failure (NYHA class II-III) were enrolled in a randomized, double-blind, crossover trial, in which the basal pacing rate was set at DDD-60 and DDD-80 for 3 months (DDD-R for 2 patients). "
05/07/2013 - "This study sought to test whether measures of pulsatile arterial function are useful for diagnosing heart failure with preserved ejection fraction (HFPEF), in comparison with and in addition to tissue Doppler echocardiography (TDE). "
12/01/2012 - "In the study, the presence and extent of cardiac dyssynchrony were investigated in patients with heart failure both with narrow and wide QRS complexes using tissue Doppler echocardiography (TDE). "
01/01/2009 - "This study was planned to investigate the normal reference values of myocardial performance index (MPI) obtained by tissue Doppler echocardiography (TDE) and the agreement between MPI measured by TDE and conventional MPI measured by pulsed-wave Doppler (PWD) in healthy subjects and patients with heart failure (HF). "
|1.||Adenosine Triphosphate (ATP)
|8.||Transferrin (beta 2 Transferrin)
|9.||Gonadal Steroid Hormones (Sex Hormones)
|10.||Immunoglobulin G (IgG)
|1.||Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
|4.||Drug Therapy (Chemotherapy)